FHI Clinical has snapped up South African CRO Triclinium Clinical Development (TCD) for an undisclosed price as the Durham, North Carolina-based group looks to expand its presence on the continent.
Moreover, FHI’s strategic expansion into private markets, particularly renewable energy, positions it to capture the fast-growing demand for alternative assets. With a conservative balance sheet, ...
Federated Hermes's 3Q25 top-line and bottom-line beat the consensus forecasts by +5% and +20%, respectively. FHI's acquisition of FCP Fund Manager broadens its U.S. real estate presence, boosts ...